Effects of SKF# 501 (N-9-fluorenyl N,N-ethyl-beta-chloroethylamine) on cardiovascular manifestations of hypoglycemia following administration of insulin.
D002319:Cardiovascular System; D006801:Humans; D006946:Hyperinsulinism; D007003:Hypoglycemia; D007328:Insulin; D013565:Sympatholytics
D007328:Insulin; D013565:Sympatholytics
CARDIOVASCULAR SYSTEM; HYPERINSULINISM; SYMPATHOLYTICS/effects